Identification and characterization of cytochrome P4502D656B (CYP2D656B), a novel allele associated with the poor metabolizer phenotype.

被引：0

作者：

Gaedigk, A. ^{[1
]}

Eklund, J. D. ^{[1
]}

Pearce, R. E. ^{[1
]}

Leeder, J. S. ^{[1
]}

Alander, S. W. ^{[1
]}

Bradford, L. D. ^{[1
]}

Kennedy, M. J. ^{[1
]}

机构：

[1] Univ Louisville, Childrens Mercy Hosp, Morehouse Sch Med, Kansas City, MO USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2007年 / 81卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：S85 / S85

页数：1

共 50 条

[41] Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotypes
Daly, AK
Fairbrother, KS
Andreassen, OA
London, SJ
Idle, JR
Steen, VM
PHARMACOGENETICS, 1996, 6 (04): : 319 - 328
[42] The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes - Author's commentary
Tucker, GT
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (07) : S748 - S749
[43] Discovery of a novel nonfunctional cytochrome P450 2D6 allele, CYP2D6*42, in African American subjects
Gaedigk, A
Ndjountché, L
Gaedigk, R
Leeder, JS
Bradford, LD
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (06) : 575 - 576
[44] Cytochrome P450 2D6 and schizophrenia.: Is the frequent CYP2D6*2 allele protective?
Meary, A.
Loriot, M. A.
Brousse, G.
Szoke, A.
Schurhoff, F.
Lancon, C.
Llorca, P. M.
Broly, F.
Beaune, P.
Leboyer, M.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 56 - 56
[45] Identification of a novel non-functional CYP2D6 allele, 2D6*42, in African Americans
Gaedigk, A
Ndjountche, L
Bradford, LD
Leeder, JS
DRUG METABOLISM REVIEWS, 2002, 34 : 151 - 151
[46] Identification of a Novel CYP2D7:CYP2D6 Hybrid Resulting in a Null Genetic Phenotype
Butz, K. G.
Murphy, M. P.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 624 - 624
[47] CYP2D7-2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype prediction
Gaedigk, Andrea
Fuhr, Uwe
Johnson, Charlene
Berard, L. Anick
Bradford, DiAnne
Leeder, J. Steven
PHARMACOGENOMICS, 2010, 11 (01) : 43 - 53
[48] The recipient CYP2D6 allele 4-associated poor metabolizer status correlates with an early fibrosis development after liver transplantation
Zimmermann, Tim
Hoppe-Lotichius, Maria
Koerner, Andreas
Lautem, Anja
Heise, Michael
Foltys, Daniel
Weiler, Nina
Biesterfeld, Stefan
Schmidtmann, Irene
Galle, Peter R.
Otto, Gerd
Schuchmann, Marcus
TRANSPLANT INTERNATIONAL, 2011, 24 (11) : 1059 - 1067
[49] A MISSENSE MUTATION IN EXON-6 OF THE CYP2D6 GENE LEADING TO A HISTIDINE-324 TO PROLINE EXCHANGE IS ASSOCIATED WITH THE POOR METABOLIZER PHENOTYPE OF SPARTEINE
EVERT, B
GRIESE, EU
EICHELBAUM, M
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1994, 350 (04) : 434 - 439
[50] The role of the poor metabolizer genotype CYP2D6 and CYP1A2 phenotype in the pharmacokinetics of duloxetine and venlafaxine-A case report
Kuzin, Maxim
Scharrer, Isabel
Nolan, Daniele
Baumgartner, Markus
Paulzen, Michael
Schoretsanitis, Georgios
Xepapadakos, Franziskos
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 127 (04) : 354 - 357

← 1 2 3 4 5 →

Identification and characterization of cytochrome P4502D6*56B (CYP2D6*56B), a novel allele associated with the poor metabolizer phenotype.

Identification and characterization of cytochrome P4502D656B (CYP2D656B), a novel allele associated with the poor metabolizer phenotype.